Picture of Kim Forest Enterprise logo

6645 — Kim Forest Enterprise Share Price

0.000.00%
tw flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+13.37%
3m-1.92%
6m+9.46%
1yr-56.07%
Volume Change (%)
10d/3m-29.51%
Price vs... (%)
52w High-40.28%
50d MA-1.63%
200d MA-9.93%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.87%
Return on Equity-28.08%
Operating Margin-22.4%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Kim Forest Enterprise EPS forecast chart

Profile Summary

KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.

Directors

Last Annual
December 31st, 2025
Last Interim
June 30th, 2026
Incorporated
August 6th, 2004
Public Since
August 18th, 2017
No. of Shareholders
6,784
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
tw flag iconTaiwan Stock Exchange
Shares in Issue
60,624,000
Blurred out image of a map
Address
4F-1, NEW TAIPEI, 221
Web
https://www.kimforest.com/
Phone
+886 226976888
Contact
Wen-Ming Yang
Auditors
PricewaterhouseCoopers LLP

6645 Share Price Performance

Upcoming Events for 6645

Similar to 6645

Picture of Abnova Taiwan logo

Abnova Taiwan

tw flag iconTaiwan Stock Exchange

Picture of Applied BioCode logo

Applied BioCode

tw flag iconTaiwan Stock Exchange

Picture of Energenesis Biomedical logo

Energenesis Biomedical

tw flag iconTaiwan Stock Exchange

Picture of HanchorBio logo

HanchorBio

tw flag iconTaiwan Stock Exchange

FAQ